期刊文献+

Lox-1——心血管疾病防治的新靶标 被引量:2

Lox-1,a new target in cardiovascular disease
下载PDF
导出
摘要 目的 Lox-1(血凝素样氧化低密度脂蛋白受体1),是ox-LDL的主要受体之一,在血管内皮功能障碍、泡沫细胞形成及动脉粥样硬化斑块的稳定性中具有重要作用。方法为了探讨Lox-1在心血管疾病中的作用,笔者对有关Lox-1在心血管疾病中的研究进展进行回顾性分析。结果 Lox-1作为ox-LDL新型清道夫受体,在心血管疾病的发生发展中具有重要的作用。结论 Lox-1可能为防治心血管疾病的药物研究提供新的思路。 Objective Lox-1( lectin-like oxidized low-density lipoprotein receptor-1) was one of the main receptor of oxLDL,which took an important role in vascular endothelial dysfunction,the formation of foam cells,and the stability of atherosclerotic plaques. To investigate the role of Lox-1 in cardiovascular diseases. Methods The literatures of Lox-1 in cardiovascular diseases retrospectively were reviewed. Results As a new ox-LDL scavenger receptor,Lox-1 played an important role in cardiovascular diseases.Conclusion Lox-1 might provide new ideas for cardiovascular diseases.
作者 李倩 芮耀诚
出处 《药学实践杂志》 CAS 2014年第5期321-323,共3页 Journal of Pharmaceutical Practice
关键词 血凝素样氧化低密度脂蛋白受体1 动脉粥样硬化 氧化低密度脂蛋白 lectin-like oxidized low-density-lipoprotein receptor-1 atherosclerosis oxidized low-density lipoprotein
  • 相关文献

二级参考文献46

  • 1Chen J,Mehta JL.Role of oxidative stress in coronary heart disease.Indian Heart J 2004; 56:163-173.
  • 2Ranganathan S,Joseph J,Mehta JL.Aspirin inhibits human coronary artery endothelial cell proliferation by upregulation of p53.Biochem Biophys Res Commun 2003; 301:143-146.
  • 3Mehta JL.Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.Clin Cardiol 1998; 21:879-884.
  • 4Mehta JL,Chen J,Yu F,Li DY.Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-l in human coronary endothelial cells.Cardiovasc Res 2004; 64:243-249.
  • 5Costanzo A,Moretti F,Burgio VL,Bravi C,Guido F,Levrero M,et al.Endothelial activation by angiotensin Ⅱ through NF kappaB and p38 pathways:Involvement of NF kappaB-inducible kinase (NIK),free oxygen radicals,and selective inhibition by aspirin.J Cell Physiol 2003; 195:402-410.
  • 6Yuan M,Konstantopoulos N,Lee J,Hansen L,Li ZW,Karin M,et al.Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.Science 2001; 293:1673-1677.
  • 7Bocan TM.Pleiotropic effects of HMG-CoA reductase inhibitors.Curr Opin Invest Drugs 2002; 3:1312-1317.
  • 8Mason RP,Walter MF,Day CA,Jacob RF.Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.Am J Cardiol 2005; 96:11-23.
  • 9Li D,Chen H,Romeo F,Sawamura T,Mehta JL.Statins modulate oxidized iow-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells:role of LOX-1.J Phannacol Exp Ther 2002; 302:601-605.
  • 10Kaneta S,Satoh K,Kant S,Kanda M,Ichihara K.All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells.Atherosclerosis 2003; 170:237-243.

共引文献56

同被引文献11

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部